Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03843515Phase 1Unknown
Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction
Oral Cavity Squamous Cell Carcinoma
PrincipalinvestigatorStart date: 2019-04-11

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Amsterdam UMC, location VUmc

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Muhammad Eyyaz Khaleel, M.Phil

Postgraduate Medical Institute, Lahore

Moderately Similar
1 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

Marc Surkin, MD

Main Line Health System

Moderately Similar
1 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

Jae Lim, Dr

Princess Alexandra Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

David Pass, Mr

Queensland Health Forensic and Scientific Services

Moderately Similar
1 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

Philippe Zrounba, M.D.

philippe.zrounba@lyon.unicancer.fr

Moderately Similar
3 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

Tayyaba Hasan, PhD

Massachusetts General Hospital, Boston, MA, United States

Moderately Similar
1 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

Simon Mueller, MD

University Hospital Inselspital, Bern, Switzerland

Moderately Similar
1 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

Jinsong Li, MD, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Moderately Similar
2 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

Adam Luginbuhl, MD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Moderately Similar
3 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma

Worked with same sponsors:

Bristol-Myers Squibb
Similarity Score30%

Nigel Brown, Dr

Princess Alexandra Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Oral Squamous Cell Carcinoma
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03843515Phase 1PrincipalInvestigator

Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction

Oral Cavity Squamous Cell Carcinoma
Unknown

All 1 trials loaded